New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 6, 2012
10:12 EDTNVGNNovogen Limited halted for volatility after jumping 83% to $4.24
News For NVGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 28, 2015
07:05 EDTNVGNNovogen announces lodgement with US Patent Office within ATM drug tech platform
Novogen announced the lodgement with the US Patent Office of a key patent covering a novel family of compounds within the company's anti-tropomyosin drug technology platform. These structurally novel compounds are related to the original ATM compounds, including lead drug candidate, Anisina. The lodgement of this new patent is part of the company's ongoing strategy of seeking a dominant, if not exclusive position, in what it believes to be an entirely new and exciting field of drug discovery. The ATM technology platform is concerned with drugs that disassemble the microfilament component of a cell's cytoskeleton. The microfilaments and microtubules are the two major structural components of the cytoskeleton, acting variously in concert and separately. The cytoskeleton plays a critical supporting role across most biological functions of a cell including the means of both internal and external communication, cell surface receptor function, cell division and cell movement.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use